ArticleFuture oncology (London, England)2025

Real-world use, effectiveness, and safety of second-line lurbinectedin monotherapy in small cell lung cancer.

Apar Kishor Ganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.